What's Happening?
Researchers have developed a new proteomic vascular mapping technique to study the blood-brain barrier (BBB), identifying proteins that regulate its permeability. Published in Science, the study by Jiefu Li and his team at the Howard Hughes Medical Institute
uses a method that profiles the luminal surface of blood vessels in vivo. This technique allows for the tracking of changes in the BBB across the aging brain and identifies proteins that could be targeted to modulate BBB permeability. The research highlights the potential for new drug delivery methods across the BBB, which is crucial for treating neurological disorders.
Why It's Important?
The blood-brain barrier is a major obstacle in the treatment of neurological diseases, as it prevents many therapeutic agents from reaching the brain. By identifying proteins that regulate BBB permeability, this research opens up new possibilities for drug delivery systems that can effectively cross the barrier. This could lead to significant advancements in the treatment of conditions such as Alzheimer's disease, multiple sclerosis, and brain tumors. The study also provides a methodology that can be applied to other organs, potentially revolutionizing the approach to drug delivery across various biological barriers.
